Starpharma Holdings Limited (ASX:SPL) Completes Patient Testing In Retention Of VivaGel Antiviral Activity Study

Starpharma Holdings Limited (ASX:SPL)(PINK:SPHRY) today announced the completion of patient testing in a clinical trial of VivaGel(R) that explores the length of time the antiviral activity of VivaGel remains following application. The study, in 12 healthy women, is designed to measure the level of antiviral activity retained by VivaGel(R) after vaginal administration, and therefore how long before sex VivaGel(R) could be applied to prevent infection.

Source: Starpharma Holdings Limited (ASX:SPL) Completes Patient Testing In Retention Of VivaGel Antiviral Activity Study